CARRARO, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 18.302
EU - Europa 13.946
AS - Asia 7.697
SA - Sud America 1.072
AF - Africa 338
Continente sconosciuto - Info sul continente non disponibili 141
OC - Oceania 32
Totale 41.528
Nazione #
US - Stati Uniti d'America 18.061
CN - Cina 2.968
GB - Regno Unito 2.962
RU - Federazione Russa 2.468
SG - Singapore 2.448
IT - Italia 1.905
IE - Irlanda 1.753
UA - Ucraina 1.141
SE - Svezia 1.019
DE - Germania 939
FR - Francia 912
BR - Brasile 893
VN - Vietnam 586
HK - Hong Kong 573
FI - Finlandia 467
KR - Corea 414
IN - India 201
ZA - Sudafrica 172
CA - Canada 108
BD - Bangladesh 88
MX - Messico 75
ES - Italia 67
TR - Turchia 63
JP - Giappone 59
AR - Argentina 56
PL - Polonia 50
IQ - Iraq 47
NL - Olanda 42
BE - Belgio 41
CZ - Repubblica Ceca 39
PK - Pakistan 38
EC - Ecuador 31
AU - Australia 30
MA - Marocco 26
NG - Nigeria 26
UZ - Uzbekistan 24
CI - Costa d'Avorio 22
ID - Indonesia 22
VE - Venezuela 22
AT - Austria 21
CL - Cile 21
KE - Kenya 21
CO - Colombia 20
EG - Egitto 19
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
TN - Tunisia 17
PH - Filippine 16
JO - Giordania 15
LT - Lituania 15
ET - Etiopia 13
JM - Giamaica 13
AZ - Azerbaigian 12
NP - Nepal 12
PY - Paraguay 12
DO - Repubblica Dominicana 11
HU - Ungheria 11
MY - Malesia 11
RO - Romania 11
CH - Svizzera 10
DZ - Algeria 10
BO - Bolivia 9
DK - Danimarca 9
GR - Grecia 8
KZ - Kazakistan 8
EU - Europa 7
IR - Iran 7
LB - Libano 7
AL - Albania 6
KG - Kirghizistan 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
EE - Estonia 5
IL - Israele 5
LV - Lettonia 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
NI - Nicaragua 4
OM - Oman 4
PE - Perù 4
TW - Taiwan 4
BB - Barbados 3
CG - Congo 3
CR - Costa Rica 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
LU - Lussemburgo 3
MD - Moldavia 3
PR - Porto Rico 3
SC - Seychelles 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
BH - Bahrain 2
GY - Guiana 2
MM - Myanmar 2
Totale 41.361
Città #
Menlo Park 3.035
Southend 2.657
Dallas 2.060
Dublin 1.743
Singapore 1.381
Ashburn 1.094
Chandler 1.078
Fairfield 1.010
Jacksonville 925
Santa Clara 780
Beijing 750
Moscow 654
San Jose 616
Milan 556
Hong Kong 548
Hefei 472
Wilmington 470
Ann Arbor 452
Woodbridge 440
Seoul 414
Council Bluffs 395
Houston 389
Seattle 377
Cambridge 366
Nanjing 333
Siena 329
Princeton 296
The Dalles 249
Los Angeles 232
Helsinki 223
New York 195
Rome 193
Ho Chi Minh City 186
Lauterbourg 173
Boardman 167
Johannesburg 151
Munich 135
Hanoi 133
Nanchang 107
Buffalo 106
Shanghai 88
San Mateo 83
Orem 79
São Paulo 77
Shenyang 69
Dearborn 67
San Diego 66
Figino 57
Kunming 57
Tianjin 53
London 52
Chennai 51
Changsha 50
Columbus 50
Bengaluru 49
Frankfurt am Main 49
Hebei 49
Turku 48
Florence 46
Fremont 44
Jiaxing 43
Tokyo 42
Turin 42
Redondo Beach 40
Redwood City 39
San Francisco 39
Brooklyn 37
Brussels 37
Manchester 37
Phoenix 37
Dong Ket 36
Düsseldorf 36
Da Nang 35
Warsaw 35
Montreal 34
Norwalk 34
Chicago 33
Málaga 33
Atlanta 32
Jinan 31
Toronto 31
Washington 31
Hangzhou 30
Rio de Janeiro 29
Guangzhou 27
Ningbo 25
Olomouc 25
Venezia 25
Abuja 24
Amsterdam 24
Haiphong 24
Stockholm 24
Boston 23
Izmir 23
Abidjan 22
Mexico City 22
Renton 22
Tashkent 22
Zhengzhou 22
Belo Horizonte 21
Totale 28.282
Nome #
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 499
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 412
Adenosine kinase gene expression in human colorectal cancer. 388
Different adaptive responses to hypoxia in normal and multiple myeloma endothelial cells 379
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors 375
Derives substitues en 4 de pyrazolo[3,4-d]pyrimidine et pyrrolo[2,3-d]pyrimidine et utilisations associees 355
The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells 339
Novel acylguanidine derivatives targeting smoothened induce antiproliferative and pro-apoptotic effects in chronic myeloid leukemia cells 328
Adaptative cellular responses to hypoxia: role of HIF-1 dependent genes in endothelial cell autophagy and survival 313
Administration of interferons and interleukin 2 via the lymphatic route 312
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl 312
Human colorectal cancer: gene expression of purine metabolism 310
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 310
Carborane-Conjugated 2-Quinolinecarboxamide Ligands of the Translocator Protein for Boron Neutron Capture Therapy 309
Design, synthesis, biological activity and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study 305
Analysis of protease-activated receptor-1 and -2 in human scar formation 304
Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway 303
The adaptor protein p66Shc is a positive regulator in the angiogenic response induced by hypoxic T cells 293
Concentrazioni plasmatiche e tissutali di interferone in pazienti sottoposti a resezione chirurgica per cancro polmonare 291
A Ribonuclease Protection Assay-Based Approach for Analysis of Angiogenic Gene Expression in Archival Tissues 287
Cell growth inhibition by interferon in hypoxia 283
The Shc protein Rai enhances T-cell survival under hypoxia 282
New 4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 273
Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma 273
Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks 272
Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells 272
Administration of the interferons via the lymphatic route 271
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs 269
Thrombin regulates the expression of pro-angiogenic cytokines via proteolytic activation of protease-activated receptor-1 267
Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function 266
The adaptor protein p66shc is a positive regulator in the angiogenic response induced by hypoxic T cells 262
Alanine kinetics in humans during low-intensity exercise 258
L'ipossia induce l'espressione del recettore attivato da proteasi-1(PAR-1) nelle cellule MDA-MB-231 mediante l'accumulo del fattore indotto dall'ipossia-1alfa 258
Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells 258
Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes 257
Hypoxia Shapes Autophagy in LPS-Activated Dendritic Cells 254
Inhibition of smoothened in breast cancer cells reduces CAXII expression and cell migration 253
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 252
Hypoxia and immune surveillance: role of the adaptor protein p66ShcA in negative regulation of T-cell activation and survival ' 251
Hedgehog signalling pathway and Carbonic Anhydrases in Breast cancer cell physiology 246
Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1α and lipopolysaccharide 245
Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype 243
Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents 242
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 238
Role of inflammatory mediators in angiogenesis 236
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes 236
Interleukin 10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of th-1-type responses 236
Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1 234
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 232
Comparative proteomic profiling of normal and breast cancer cells under hypoxic conditions 230
Pirazolo[3,4-d]pirimidine come nuovi agenti antiproliferativi. Sviluppo di un modello 3D QSAR a bassa dipendenza conformazionale 230
Hypoxia induces the expression and release of interleukin 1 receptor antagonist in mitogen-activated mononuclear cells 230
Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells 228
Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases 227
Pro·angiogenic signaling in neuroblastoma: interplay between HIF-1a and Shc C adaptor protein 226
Different expression of cytokines and receptors in bleomycin-sensitive and resistant mice 222
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 222
Thrombin inhibits IFN-gamma production in human peripheral blood mononuclear cells by promoting a Th2 profile 220
Regulation of angiogenesis by Th1- and Th2-type cytokines 220
‘HIF-1 dependent adaptative responses to hypoxia: pro-survival and pro-apoptotic signaling pathways 220
Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells 219
HIF-1 upregulation by IL-1 contributes to the migratory potential of breast cancer cells 219
The possible role of T cells and neutrophils in the regulation of tumour angiogenesis 219
Interferon (IFN) levels in human pulmonary tumors 217
The effects of autologous platelet gel on inflammatory cytokine response in human peripheral blood mononuclear cells 214
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1alpha in breast cancer cells 213
Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses 212
Alpha-thrombin reverses differentiation-related changes in expression of P21CIP1/WAF1 in interferon-gamma differentiated monocytic cells 212
Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression 211
CA-IX-Expressing Small Extracellular Vesicles (sEVs) Are Released by Melanoma Cells under Hypoxia and in the Blood of Advanced Melanoma Patients 208
Whole body and plasma protein synthesis in exercise and recovery in human subjects 207
Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells 207
Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1αand NFκB Transcription Factors 207
Human alpha-Thrombin Stimulates Proliferation of Interferon-gamma Differentiated, Growth-Arrested, U937 Cells, Overcoming Differentiation-Related Changes in Expression of p21CIP1/WAF1 and Cyclin D1 206
Structure-Based Optimization of Pyrazolo[3,4-d]pyrimidines as Abl Inhibitors and Antiproliferative Agents toward Human Leukemia Cell Lines. 205
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines. 205
Hypoxia triggers autophagy in human monocyte-derived dendritic cells 204
Targeting hypoxia signaling pathways in angiogenesis 203
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 203
SQSTM1/p62 inhibition impairs pro-survival signaling in hypoxic human dendritic cells 202
Urea kinetics in humans at two levels of exercise intensity 202
Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation 202
The thrombin peptide, TP508, enhances cytokine release and activates signaling events 202
Role of p52RAI Shc protein in the adaptive response to hypoxia in T cells 201
Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors 201
Hypoxia induces autophagy in human monocyte-derived dendritic cells: involvement of Class III PI3K/VPS34 199
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1α in MDA-MB-231 breast cancer cells 199
Quantification of incorporation of [15N]ammonia into plasma amino acids and urea 198
p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells 197
Hypoxia induces coordinated adaptive responses in SK-N-MC neuronal cells towards a pro-angiogenic and migratory phenotype 197
Cytokine expression in bleomycin-sensitive and resistant mice 196
Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach 195
Role of the Hypoxia-Inducible Factor-1alpha and Akt on hypoxia-induced migratory program in dendritic cells 195
Regulation of HMG-CoA reductase expression by hypoxia 195
Interferon levels in human pulmonary tumors are lower than plasma levels 194
Regulation of the hypoxia-inducible factor (HIF)-1α by interleukin-1: implication for breast cancer cell migration in the tumor microenvironment 194
Ozonation of human blood induces a remarkable upregolation of heme oxygenase-1 and heat stress protein-70 190
Protease-activated receptor-1 and tumor microenvironment: new insights in the inflammation-tumor progression network 190
p66Shc promotes apoptosis and antagonises mitogenic signaling in T cells. 189
Inhibition of CAXII impaired melanoma cell migration and invasion under hypoxia 187
Totale 24.734
Categoria #
all - tutte 119.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.042 0 281 121 237 99 36 83 159 124 214 171 517
2022/20233.909 240 255 589 584 385 789 52 284 444 61 139 87
2023/20242.594 102 65 222 121 96 711 911 124 13 31 28 170
2024/20255.092 125 317 486 227 675 223 99 292 405 161 547 1.535
2025/202612.797 943 1.861 1.631 1.341 2.403 401 1.292 399 559 716 214 1.037
2026/2027909 561 348 0 0 0 0 0 0 0 0 0 0
Totale 41.528